We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Citizen Petition Process Needs Reforming, FDA Chief Counsel Says
Citizen Petition Process Needs Reforming, FDA Chief Counsel Says
October 4, 2005
The FDA’s chief counsel wants to reform the citizen petition process to discourage brand drugmakers from filing petitions simply to delay generic drug debuts.